Trinity Biotech - 24 Year Stock Price History | TRIB

Historical daily share price chart and data for Trinity Biotech since 1995 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Trinity Biotech as of January 18, 2019 is 2.71.
Trinity Biotech Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.5438 2.3100 2.7800 2.3100 2.7100 18.34%
2018 4.4185 5.1800 6.0600 2.1400 2.2900 -55.10%
2017 5.6609 6.9600 7.0400 4.5000 5.1000 -26.30%
2016 10.3162 11.6800 13.5300 6.3100 6.9200 -41.16%
2015 15.7967 17.9300 19.8070 10.8300 11.7600 -32.01%
2014 21.7848 24.3824 27.2797 15.8555 17.2978 -29.71%
2013 18.6682 14.2047 25.0871 14.1079 24.6075 76.36%
2012 11.6524 9.6455 14.9014 9.3972 13.9531 43.52%
2011 9.2239 8.0932 10.3426 7.8474 9.7219 16.72%
2010 5.8114 3.7606 8.4147 3.6306 8.3296 118.07%
2009 3.0323 1.5506 4.6801 0.9927 3.8197 152.51%
2008 3.5104 6.2306 6.5710 1.1818 1.5127 -76.51%
2007 9.3563 8.3107 11.1093 5.4081 6.4387 -20.54%
2006 8.1028 7.7623 9.0198 6.7034 8.1027 5.03%
2005 7.7621 11.0809 11.0809 5.9375 7.7150 -31.08%
2004 12.3019 20.0817 20.0817 9.5681 11.1943 -46.95%
2003 10.4951 5.4837 23.4060 4.7273 21.1028 313.33%
2002 5.0907 5.6728 6.9586 3.5171 5.1055 -11.18%
2001 7.2352 8.5092 11.3456 4.3113 5.7484 -32.44%
2000 12.6798 6.6183 28.1371 6.6183 8.5092 33.14%
1999 6.4642 5.5594 8.5092 4.3870 6.3914 29.01%
1998 6.8703 7.7907 9.6816 3.5550 4.9543 -33.50%
1997 9.5882 8.7361 11.9507 6.1645 7.4503 -15.81%
1996 14.0297 13.6904 24.1283 8.5092 8.8496 -39.69%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.065B $0.099B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $125.437B 25.42
Medtronic (MDT) Ireland $117.248B 17.53
Stryker (SYK) United States $62.695B 23.63
Boston Scientific (BSX) United States $52.155B 26.36
Baxter (BAX) United States $37.585B 24.27
Zimmer Biomet Holdings (ZBH) United States $21.487B 13.93
ResMed (RMD) United States $16.792B 32.02
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
Canopy Growth (CGC) Canada $10.104B 0.00
Bio-Rad Laboratories (BIO) United States $7.180B 45.91
Hill-Rom Holdings (HRC) United States $6.608B 20.68
Aurora Cannabis (ACB) Canada $6.428B 33.90
Perrigo (PRGO) Ireland $6.245B 9.48
Haemonetics (HAE) United States $5.216B 45.87
ICU Medical (ICUI) United States $4.878B 27.18
Insulet (PODD) United States $4.428B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.141B 0.00
Agios Pharmaceuticals (AGIO) United States $3.252B 0.00
Neogen (NEOG) United States $3.150B 48.38
Hutchison China MediTech (HCM) China $2.945B 0.00
National Vision Holdings (EYE) United States $2.566B 49.63
NuVasive (NUVA) United States $2.469B 22.98
Quidel (QDEL) United States $2.084B 27.17
NxStage Medical (NXTM) United States $1.901B 0.00
Aphria (APHA) $1.668B 74.22
Phibro Animal Health (PAHC) United States $1.294B 18.32
AtriCure (ATRC) United States $1.222B 0.00
VAREX IMAGING (VREX) United States $1.060B 21.23
Cardiovascular Systems (CSII) United States $1.013B 1457.00
PetIQ (PETQ) United States $0.781B 20.25
Cerus (CERS) United States $0.771B 0.00
OraSure Technologies (OSUR) United States $0.747B 42.03
Meridian Bioscience (VIVO) United States $0.713B 22.73
Eagle Pharmaceuticals (EGRX) United States $0.662B 21.24
Omeros (OMER) United States $0.658B 0.00
Surmodics (SRDX) United States $0.642B 97.18
Lantheus Holdings (LNTH) United States $0.637B 19.73
NanoString Technologies (NSTG) United States $0.624B 0.00
MacroGenics (MGNX) United States $0.520B 0.00
Quanterix (QTRX) United States $0.467B 0.00
LeMaitre Vascular (LMAT) United States $0.458B 22.48
Owens & Minor (OMI) United States $0.453B 5.12
Evolus (EOLS) United States $0.436B 0.00
TG Therapeutics (TGTX) United States $0.375B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.85
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.279B 0.00
Bovie Medical (APYX) United States $0.278B 0.00
Vapotherm (VAPO) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.244B 0.00
BioLife Solutions (BLFS) United States $0.226B 305.00
Rockwell Medical (RMTI) United States $0.198B 0.00
Fonar (FONR) United States $0.139B 7.00
Chimerix (CMRX) United States $0.137B 0.00
Surface Oncology (SURF) United States $0.136B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
United-Guardian (UG) United States $0.090B 18.85
Female Health (VERU) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00